15 Stocks to Double In 2017: FEYE, GM, CHK, MRO, & SRPT Stock

If FireEye, General Motors, Chesapeake, Marathon, and Sarepta manage risks, then FEYE, GM, CHK, MRO, & SRPT stock will double in 2017.

Posted in BNL Reports, Hot Stocks, Members | Tagged , , , , , , , , , | Leave a comment

Why Sarepta Therapeutics (SRPT) Stock Will Double Over Next 12-Months

Sarepta Therapeutics investors should not worry about the FDA or a slow launch for Exondys 51; investors should expect SRPT stock soar short-term.

Posted in BNL Reports, Healthcare & Biotech | Tagged , , , , , , , | Leave a comment

These 10 Biotech Stocks Will Be M&A Targets

These biotech stocks are all prime M&A targets: Gilead Sciences Inc, Alexion Pharmaceuticals, Inc., ACADIA Pharmaceuticals Inc., Sarepta Therapeutics Inc, Intercept Pharmaceuticals Inc, Juno Therapeutics Inc, Kite Pharma Inc, Regeneron Pharmaceuticals Inc, Biogen Idec, and Celldex Therapeutics, Inc.

Posted in Healthcare & Biotech, Mergers & Acquisitions | Tagged , , , , , , , , , , , , , , , , , , , , , | Leave a comment